Tender

Dose banded compounded chemotherapy

  • Berkshire Healthcare NHS Foundation Trust

UK4: Tender notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2026/S 000-014039

Procurement identifier (OCID): ocds-h6vhtk-065564

Published 16 February 2026, 5:09pm



Scope

Reference

BHFT 0745

Description

Pharmacy Procurement Contract - A

ranked framework for the supply and

delivery of Supply of Dose banded compounded chemotherapy

split into 2 lots:

Lot 1: Products - 7 molecules / all brands

Lot 2: Products - 13 molecules / all brands

The ranked framework will be open to

the participating Trusts of the South

East Pharmacy Procurement Service

(SEPPS): Thames Valley and Wessex (TV&W)

1. Ashford and St Peters Hospital NHS Foundation Trust

2. Berkshire Healthcare NHS Foundation Trust

3. Buckinghamshire Healthcare NHS Trust

4. Dartford and Gravesham NHS Trust

5. East Kent Hospitals NHS Foundation Trust

6. East Sussex Healthcare NHS Trust

7. Frimley Health NHS Foundation Trust

8. Hampshire and Isle of Wight Healthcare NHS Foundation Trust

9. Hampshire Hospitals NHS Foundation Trust

10. Isle of Wight NHS Trust

11. Kent Community Health NHS Trust

12. Maidstone and Tunbridge Wells NHS Trust

13. Medway NHS Foundation Trust

14. Milton Keynes University Hospital NHS Foundation Trust

15. Oxford Health NHS Foundation Trust

16. Oxford University Hospitals NHS Foundation Trust *

17. Portsmouth Hospitals NHS Trust

18. Queen Victoria Hospitals NHS Foundation Trust

19. Royal Berkshire NHS Foundation Trust

20. Royal Surrey County Hospital NHS Foundation Trust

21. Surrey and Borders Partnership NHS Foundation Trust

22. Surrey and Sussex Healthcare NHS Trust

23. Sussex Community NHS Trust

24. Sussex Partnership NHS Foundation Trust

25. University Hospital Southampton NHS Foundation Trust

26. University Hospitals Sussex NHS Foundation Trust

This framework will be available for use

by Trusts in East of England and

London regions, but the volumes for

these regions have not been included

for adjudication as part of the tender

process.

SEC Trusts can utilise this tender for

products or services not covered by the

National unlicensed aseptically

prepared cytotoxic medicines and

Dose banded compounded chemotherapy framework via MPSC.

Please note: we did not publish a

preliminary market engagement notice

(UK2) for the following reasons:

- we are not seeking to further develop

our requirements or procurement

approach.

- we have procured similar supply

arrangements via the Open procedure

and deployed similar conditions of

participation and award criteria. These

have yielded good results previously.

- we have already prepared our tender

pack (see attached), that detail

standard NHS contractual terms which

have been found to be acceptable to

the supply chain.

- we understand the likely suppliers

who will be interested but the open

notice approach gives opportunity to

others looking to enter the Dose banded compounded chemotherapy supply market

Commercial tool

Establishes a framework

Total value (estimated)

  • £17,250,000,000 excluding VAT
  • £20,700,000,000 including VAT

Above the relevant threshold

Contract dates (estimated)

  • 31 August 2026 to 30 August 2028
  • 2 years

Main procurement category

Services

CPV classifications

  • 33600000 - Pharmaceutical products
  • 85149000 - Pharmacy services

Contract locations

  • UK - United Kingdom
  • UKJ - South East (England)

Lot 1. Lot 1 - High Volume

Description

Expected High Volume Demand

Lot value (estimated)

  • £11,557,500 excluding VAT
  • £13,869,000 including VAT

Framework lot values may be shared with other lots

Same for all lots

CPV classifications, contract locations and contract dates are shown in the Scope section, because they are the same for all lots.


Lot 2. Lot 2 - Low Volume

Description

Expected Low Volume Demand

Lot value (estimated)

  • £5,692,500 excluding VAT
  • £6,831,000 including VAT

Framework lot values may be shared with other lots

Same for all lots

CPV classifications, contract locations and contract dates are shown in the Scope section, because they are the same for all lots.


Framework

Maximum number of suppliers

Unlimited

Maximum percentage fee charged to suppliers

0%

Framework operation description

The Contracting Authorities reserve the

right to maintain supply with the

incumbent Supplier to maintain

continuity of care for patients.

Framework call-off rules require the

highest ranked Supplier for each LOT

will be approached first to provide

Services. Only should the highest

ranked Supplier not be able to meet the

demand and provide an acceptable

product, will the next highest ranked

Supplier be approached.

Award method when using the framework

Without competition

Contracting authorities that may use the framework

The ranked framework will be open to

the participating Trusts of the South

East Pharmacy Procurement Service

(SEPPS). See Contract Description.


Participation

Legal and financial capacity conditions of participation

Lot 1. Lot 1 - High Volume

Lot 2. Lot 2 - Low Volume

See Tender Pack

Particular suitability

Lot 1. Lot 1 - High Volume

Lot 2. Lot 2 - Low Volume

  • Small and medium-sized enterprises (SME)
  • Voluntary, community and social enterprises (VCSE)

Submission

Enquiry deadline

11 March 2026, 12:00pm

Tender submission deadline

20 March 2026, 12:00pm

Submission address and any special instructions

Tenders may be submitted electronically

Yes

Languages that may be used for submission

English

Award decision date (estimated)

15 June 2026

Recurring procurement

Publication date of next tender notice (estimated): 6 July 2027


Award criteria

This table contains award criteria for this lot
Name Description Type Weighting
Price

See ITT Instructions

Price 35.00%
Technical Questions

See ITT Instructions

Quality 23.99%
Technical Compliance

See ITT Instructions

Quality 16.00%
Shelf Life

See ITT Instructions

Quality 15.00%
Social Value

See ITT Instructions

Quality 10.00%
Conditions of Participation

Pass/Fail

Quality 0.01%

Other information

Payment terms

30 day payment terms as set out in the

Tender Pack - see 'PR BHFT 0745 -

ITT Open - Schedule 7 - Draft

Contract'.

Description of risks to contract performance

The following have been identified as

‘Known Risks’:

Denial of access to raw material medicines to Suppliers, which increases the cost of Dose Banded Compounded Chemotherapy ,or brands on the Framework Agreement. Where this can be demonstrated by the Supplier, the Price for affected Dose Banded Compounded Chemotherapy will be agreed and the Framework Prices modified as a Variation which may result in the overall Framework Agreement value increasing.

Conflicts assessment prepared/revised

Yes


Procedure

Procedure type

Open procedure


Documents

Associated tender documents

PR BHFT 0745 - Tender Pack.zip


Contracting authority

Berkshire Healthcare NHS Foundation Trust

  • Public Procurement Organisation Number: PVLX-5425-VJZN

London House, London Road

Bracknell

RG12 2UT

United Kingdom

Region: UKJ11 - Berkshire

Organisation type: Public authority - central government